The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration
Abstract
Background Early reports suggested that corticobasal degeneration (CBD) is a distinct clinicopathologic entity. Because patients have had a fairly consistent constellation of clinical and laboratory findings, many have proposed that the pathologic diagnosis can be surmised with confidence during life. Objective To analyze the pathologic findings in a large series of cases with clinically diagnosed CBD. Methods Using the medical research linkage system of the Mayo Clinic for the period January 1990 to December 1997, we identified cases diagnosed during life with CBD who subsequently underwent autopsy. All patients had progressive asymmetric rigidity and apraxia (except one with rigidity but no apraxia) with other findings, suggesting additional cortical and basal ganglionic dysfunction. All cases underwent standardized neuropathologic examination with the distribution and severity of the pathologic changes determined for each case and the pathologic diagnoses based on currently accepted criteria. Results Thirteen cases were identified. The pathologic diagnoses were CBD in seven, AD in two, and one each for progressive supranuclear palsy, Pick's disease, nonspecific degenerative changes, and Creutzfeldt-Jakob disease. Two cases had negligible basal ganglia and nigral degeneration despite previously having obvious extrapyramidal signs. However, all patients had focal or asymmetric cortical atrophy with coexisting neuronal loss and gliosis with or without status spongiosis, which…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This phenotypic variability results in <50% of patients with CBS having CBD at autopsy567.”
From Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy (2015) · cites this paper as [7]
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationRochester, C. L., & Kradin, R. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432509 · Cited by 3,875
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C., & Gilman, S. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 664
Corticodentatonigral Degeneration With Neuronal Achromasia
Rebeiz, J. J., Kolodny, E. H., & Richardson, E. P. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00470310034003 · Cited by 627
Cortical‐basal ganglionic degeneration
Riley, D. E., Lang, A. E., Lewis, A., Resch, L., Ashby, P., Hornykiewicz, O., & Black, S. E. (1990) · Neurology · doi:10.1212/wnl.40.8.1203 · Cited by 570
Corticobasal degeneration: A clinical study of 36 cases
Rinne, J. O., Lee, M. S., Thompson, P. D., & MARSDEN, C. D. (1994) · Brain · doi:10.1093/brain/117.5.1183 · Cited by 407
Accuracy of the Clinical Diagnosis of Corticobasal Degeneration
Litvan, I., Agid, Y., Goetz, C. G., Jankovic, J. J., Wenning, G. K., Brandel, J., Lai, E. C., Verny, M., Chaudhuri, К. R., McKee, A. C., et al. (1997) · Neurology · doi:10.1212/wnl.48.1.119 · Cited by 377
Wenning, G. K., Litvan, I., Jankovic, J. J., Granata, R., Mangone, C. A., McKee, A. C., Poewe, W. H., Jellinger, K. A., Chaudhuri, К. R., D'Olhaberriague, L., et al. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.2.184 · Cited by 343
Widespread cytoskeletal pathology characterizes corticobasal degeneration.
Feany, M. Β., & Dickson, D. W. (1995) · PubMed Central · Cited by 275
Self-citation
Flagged first, then by citations
Research works printed but not linked: 8
- 10.1212/WNL.39.1.140 · DOI
- Rosenfield D, Bogatka C, Viswanath N, Lang A, Jankovic J. Speech apraxia in cortico-basal ganglionic degeneration. Ann Neurol 1991;30:296–297.
- Lang A Riley D Bergeron C. Cortical-basal ganglionic degeneration. In: Calne D ed. Neurodegenerative diseases. Philadelphia:WB Saunders 1994:877–894.
- Watts R Mirra S Richardson E. Corticobasal ganglionic degeneration. In: Marsden C Fahn S eds. Movement disorders 3. Oxford:Butterworth-Heinemann 1994:282–299.
- Cambier J, Masson M, Dairou R, Henin D. Etude anatomo-clinique d’une forme parietale de maladie de Pick. Rev Neurol (Paris) 1981;137:33–38.
- Cannard K, Galvez-Jimenez N, Watts R. Creutzfeldt-Jakob disease presenting and evolving as rapidly progressive corticobasal degeneration. Neurology 1998;50 (suppl 4):A95. Abstract.
- Heilman K Gonzales-Rothi L. Apraxia. In: Heilman K Valenstein E eds. Clinical neuropsychology. New York:Oxford University Press 1985:131–150.
- Goldhammer L. The apraxic and parietal hand and their definite localizing value tonic, motor, and visuokinetic phenomena in parietal lobe syndromes. Neurology 1989;39 (suppl 1):225. Abstract.
Cited by
Sorted by citations
Items 401–416 of 416
The Cognitive Neurology of Corticobasal Degeneration and Progressive Supranuclear Palsy
Lee, S. E., & Fredericks, C. A. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.013
Cognitive profile accurately predicts underlying pathology in Corticobasal SyndromePreprint
Smithies, S., Ebneabbasi, A., Conci, R., Murley, A. G., Savulich, G., Stockton, K. C., Rouse, M. A., Naessens, M., Malpetti, M., Rittman, T., et al. (2025) · medRxiv · doi:10.64898/2025.12.17.25342469
Lehmann, S., Dumurgier, J., Ayrignac, X., Marelli, C., Alcolea, D. A., Fortea, J., Thouvenot, É., Delaby, C., Hirtz, C., Vialaret, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13047440
Lehmann, S., Dumurgier, J., Ayrignac, X., Marelli, C., Alcolea, D. A., Fortea, J., Thouvenot, É., Delaby, C., Hirtz, C., Vialaret, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13047446
Lehmann, S., Dumurgier, J., Ayrignac, X., Marelli, C., Alcolea, D. A., Fortea, J., Thouvenot, É., Delaby, C., Hirtz, C., Vialaret, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13047443
Lehmann, S., Dumurgier, J., Ayrignac, X., Marelli, C., Alcolea, D. A., Fortea, J., Thouvenot, É., Delaby, C., Hirtz, C., Vialaret, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13047449
Lehmann, S., Dumurgier, J., Ayrignac, X., Marelli, C., Alcolea, D. A., Fortea, J., Thouvenot, É., Delaby, C., Hirtz, C., Vialaret, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13047452
Koga, S., Metrick, M. A., Golbe, L. I., Santambrogio, A., Kim, M., Soto‐Beasley, A. I., Walton, R. L., Baker, M., De Castro, C. F., Deture, M. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26593406
Self-citationMorihara, R., Nomura, E., Osakada, Y., Yunoki, T., Takemoto, M., Yamashita, T., & Ishiura, H. (2026) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2026.108229
КЛІНІКО-ПАРАКЛІНІЧНІ ОСОБЛИВОСТІ КОРТИКО-БАЗАЛЬНОЇ ДЕГЕНЕРАЦІЇ
Сохор, Н. Р., & Ясний, О. Р. (2026) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2025.v.i4.15813
MRT-Bildgebung bei neurodegenerativen Parkinson-Syndromen
Schröter, N., Rau, A., Reith, W., Martens, D., González‐Escamilla, G., & Groppa, S. (2026) · Die Radiologie · doi:10.1007/s00117-026-01585-8
Neurodegenerative diseases and myoclonus
Grippe, T. C., Falletti, M., Suppa, A., & Chen, R. (2026) · International review of movement disorders · doi:10.1016/bs.irmvd.2026.06.002
Saim, M. S., Al-Kazzaz, H., & Ahmad, H. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09276-x
Toward implementable biomarkers for corticobasal syndrome: A narrative review
Koga, S., & Nakano, Y. (2026) · NeuroMarkers. · doi:10.1016/j.neumar.2026.100236
The Adult Neurogenesis Theory of Alzheimer’s Disease Predicts Where Tauopathy Develops in the Brain
Abbate, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198776
Metadata
- Authors
- Boeve, B. F., Maraganore, D. M., Parisi, J. E., Ahlskog, J. E., Graff-Radford, N., Caselli, R. J., Dickson, D. W., Kokmen, E., & Petersen, R. C.
- Affiliations
- Mayo Clinic (US)
- From the Departments of Neurology (Drs. BoeveMaraganore, Ahlskog, Kokmen, and Petersen), Laboratory Medicine and Pathology (Dr. Parisi), Mayo Clinic, Rochester, MN; Department of Neurology (Dr. Graff-Radford) and the Neuropathology Laboratory (Dr. Dickson), Mayo Clinic, Jacksonville, FL; and Department of Neurology (Dr. Caselli), Mayo Clinic, Scottsdale, AZ.
- Venue
- Neurology
- Published
- 1999-09
- Volume
- 53
- Issue
- 4
- Pages
- 795-795
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1986748953
- Cited by
- 417
- References
- 41
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 8 · 2022: 11 · 2021: 14 · 2020: 22 · 2019: 10 · 2018: 10 · 2017: 21 · 2016: 15 · 2015: 19 · 2014: 21 · 2013: 21 · 2012: 13
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-08031, P30AG008031)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- corticobasal degeneration, clinicopathological correlation, cortical atrophy, basal ganglia degeneration, nigral degeneration, extrapyramidal signs, apraxia, progressive supranuclear palsy, Pick's disease, Creutzfeldt-Jakob disease, gliosis, neuropathologic diagnosis
- MeSH terms
- Aged, Basal Ganglia Diseases, Brain, Female, Humans, Male, Middle Aged, Prospective Studies, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
